• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Introduction to 2-benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine (CAS No. 351370-98-4)

2-benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine, identified by the Chemical Abstracts Service Number (CAS No.) 351370-98-4, is a structurally complex organic compound belonging to the class of heterocyclic amines. This compound has garnered significant attention in the field of pharmaceutical chemistry due to its unique structural framework and potential biological activities. The presence of both a benzyl group and an octahydro-1H-pyrrolo[3,4-c]pyridine core suggests a high degree of molecular complexity, which may contribute to its pharmacological properties.

The octahydro-1H-pyrrolo[3,4-c]pyridine scaffold is a fused ring system consisting of a pyrrole ring connected to a piperidine ring, both of which are saturated. This type of structure is commonly found in various bioactive molecules and has been extensively studied for its potential applications in drug discovery. The benzyl group attached to the pyrrolopyridine system introduces additional functionalization possibilities, enabling modifications that could fine-tune the compound's biological profile.

In recent years, there has been growing interest in developing novel heterocyclic compounds for therapeutic applications. The 2-benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine scaffold has emerged as a promising candidate due to its ability to interact with biological targets in unique ways. Studies have shown that derivatives of this compound can exhibit properties such as receptor binding affinity and enzyme inhibition, making it a valuable scaffold for medicinal chemists.

One of the most compelling aspects of 2-benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine is its potential as a lead compound for drug development. Researchers have been exploring its interactions with various biological targets, including G-protein coupled receptors (GPCRs) and ion channels. The benzyl group provides a handle for further chemical modifications, allowing scientists to optimize the compound's pharmacokinetic and pharmacodynamic properties. This flexibility makes it an attractive candidate for structure-activity relationship (SAR) studies.

The synthesis of 2-benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Common synthetic routes include cyclization reactions followed by functional group transformations to introduce the benzyl moiety. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to explore its biological potential in preclinical studies.

Recent research has highlighted the biological activity of 2-benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine and its derivatives. For instance, studies have demonstrated that certain analogs of this compound exhibit inhibitory effects on specific enzymes implicated in neurological disorders. The precise binding interactions between these compounds and their targets are being elucidated through computational modeling and experimental techniques such as X-ray crystallography. These insights are crucial for understanding the mechanisms of action and for designing more effective therapeutic agents.

The potential therapeutic applications of 2-benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine are broad and span multiple disease areas. Initial findings suggest that this compound may have utility in treating conditions such as depression, anxiety disorders, and pain syndromes. The ability to modulate neurotransmitter systems makes it an attractive candidate for central nervous system (CNS) drug development. Additionally, the structural features of this compound may contribute to its potential as an anti-inflammatory agent or an antioxidant.

In conclusion, 2-benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine (CAS No. 351370-98-4) represents a significant advancement in the field of pharmaceutical chemistry. Its unique structural features and demonstrated biological activity make it a valuable scaffold for drug discovery efforts. As research continues to uncover new applications for this compound and its derivatives, it is likely to play an increasingly important role in the development of novel therapeutics.

• 372963-42-3((S)-(1-Benzylpiperidin-3-yl)methanamine)
• 99735-27-0(2,7-Diazaspiro[4.4]nonane, 2-methyl-7-(phenylmethyl)-)
• 99735-28-1(2,7-Diazaspiro[4.4]nonane, 2-ethyl-7-(phenylmethyl)-)
• 867009-61-8(2-benzyl-2,8-diazaspiro[4.5]decane)
• 64097-82-1(2,8-Diazaspiro[4.5]decane, 2-methyl-8-(phenylmethyl)-)
• 124257-62-1((1-Benzylpiperidin-3-yl)methylamine)
• 1086395-71-2(2-Benzyl-2,7-diazaspiro[4.5]decane)
• 1086395-18-7(7-benzyl-2,7-diazaspiro[4.5]decane)
• 134574-95-1((3-benzyl-3-azabicyclo[3.1.0]hexan-1-yl)methanamine)
• 186203-32-7(5-benzyl-octahydro-1H-pyrrolo[3,4-c]pyridine)